ArticleBMJ health & care informatics2026
Machine learning-based prediction of shigellosis in children under five: development and internal validation of a prediction model.
Article in BMJ health & care informatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesShigella remains a major cause of diarrhoea and mortality in children under five in low- and middle-income countries, where laboratory confirmation is often inaccessible and dysentery-based management lacks sensitivity. This study aimed to develop and internally evaluate machine learning models to predict microbiologically confirmed
methodsWe analysed data from 3356 children with diarrhoea enrolled in the Global Enteric Multicentre Study, excluding co-infections and non-diarrhoeal controls. Multiple machine learning algorithms were trained using 32 predictors and evaluated with 10-fold cross-validation. Performance was assessed using area under the receiver operating characteristic curve (AUC), recall and Brier score, with recall prioritised to minimise false negatives. The selected model was simplified using the 10 most informative predictors and integrated into a prototype web-based application. All analyses were restricted to internal validation.
resultsSupport vector machine (SVM) demonstrated the highest recall (0.64) with modest but potentially useful discrimination (AUC 0.74). The parsimonious SVM model achieved recall 0.67, AUC 0.77 and Brier score 0.16. A web-based prototype was developed to illustrate real-time model outputs for research purposes. DISCUSSION: The model achieved moderate internal performance while prioritising recall, supporting its potential role as a research-stage risk stratification tool in settings with limited diagnostic capacity.
conclusionThis internally validated model shows potential for supporting risk stratification for shigellosis. External validation and impact evaluation are required before clinical or operational use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.